The phage lysin PlySs2 Decolonizes Streptococcus suis from murine intranasal mucosa

PLoS ONE

Volumn 12, Issue 1, 2017, Pages

  Gilmer, Daniel B ^a   Schmitz, Jonathan E ^a,b   Thandar, Mya ^a   Euler, Chad W ^a   Fischetti, Vincent A ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; HYDROLASE; PHAGE LYSIN STREPTOCOCCUS SUIS 2; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ENZYME; LYSIN, STREPTOCOCCUS BACTERIOPHAGE; PENICILLIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; INFECTION PREVENTION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; NOSE MUCOSA; PIG; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PHAGE; STREPTOCOCCUS SUIS; ANIMAL; BACTERIOPHAGE; MICROBIOLOGY; MOLECULAR CLONING; PATHOGENICITY; STREPTOCOCCAL INFECTIONS; SWINE DISEASES; ZOONOSES;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIOPHAGES; CLONING, MOLECULAR; ENZYMES; FEMALE; GENTAMICINS; MICE; NASAL MUCOSA; PENICILLINS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PHAGES; STREPTOCOCCUS SUIS; SUS SCROFA; SWINE; SWINE DISEASES; ZOONOSES;

EID: 85008197498     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0169180     Document Type: Article

References (41)

1. Silva LM, Baums CG, Rehm T, Wisselink HJ, Goethe R, Valentin-Weigand P. Virulence-associated gene profiling of Streptococcus suis isolates by PCR. Veterinary microbiology. 2006; 115(1-3):117-27. Epub 2006/01/25. doi: 10.1016/j.vetmic.2005.12.013 PMID: 16431041
2. Wu Z, Zhang W, Lu C. Comparative proteome analysis of secreted proteins of Streptococcus suis serotype 9 isolates from diseased and healthy pigs. Microbial pathogenesis. 2008; 45(3):159-66. Epub 2008/06/17. doi: 10.1016/j.micpath.2008.04.009 PMID: 18554861
3. Gottschalk M, Xu J, Calzas C, Segura M. Streptococcus suis: a new emerging or an old neglected zoonotic pathogen? Future Microbiol. 2010; 5(3):371-91. Epub 2010/03/10. doi: 10.2217/fmb.10.2 PMID: 20210549
4. Sriskandan S, Slater JD. Invasive disease and toxic shock due to zoonotic Streptococcus suis: an emerging infection in the East? PLoS Med. 2006; 3(5):e187. Epub 2006/04/06. doi: 10.1371/journal.pmed.0030187 PMID: 16594733
5. Kerdsin A, Dejsirilert S, Puangpatra P, Sripakdee S, Chumla K, Boonkerd N, et al. Genotypic profile of Streptococcus suis serotype 2 and clinical features of infection in humans, Thailand. Emerg Infect Dis. 2011; 17(5):835-42. doi: 10.3201/eid1705.100754 PMID: 21529392
6. Dekker N, Bouma A, Daemen I, Klinkenberg D, van Leengoed L, Wagenaar JA, et al. Effect of spatial separation of pigs on spread of Streptococcus suis serotype 9. PloS one. 2013; 8(4):e61339. Epub 2013/04/18. doi: 10.1371/journal.pone.0061339 PMID: 23593467
7. Arends JP, Zanen HC. Meningitis caused by Streptococcus suis in humans. Rev Infect Dis. 1988; 10(1):131-7. Epub 1988/01/01. PMID: 3353625
8. Perch B, Kristjansen P, Skadhauge K. Group R streptococci pathogenic for man. Two cases of meningitis and one fatal case of sepsis. Acta pathologica et microbiologica Scandinavica. 1968; 74(1):69-76. Epub 1968/01/01. PMID: 5700279
9. Yu H, Jing H, Chen Z, Zheng H, Zhu X, Wang H, et al. Human Streptococcus suis outbreak, Sichuan, China. Emerg Infect Dis. 2006; 12(6):914-20. Epub 2006/05/19. doi: 10.3201/eid1206.051194 PMID: 16707046
10. Trottier S, Higgins R, Brochu G, Gottschalk M. A case of human endocarditis due to Streptococcus suis in North America. Reviews of infectious diseases. 1991; 13(6):1251-2. Epub 1991/11/01. PMID: 1775866
11. Cantin M, Harel J, Higgins R, Gottschalk M. Antimicrobial resistance patterns and plasmid profiles of Streptococcus suis isolates. J Vet Diagn Invest. 1992; 4(2):170-4. Epub 1992/04/01. PMID: 1616981
12. Varela NP, Gadbois P, Thibault C, Gottschalk M, Dick P, Wilson J. Antimicrobial resistance and prudent drug use for Streptococcus suis. Animal health research reviews / Conference of Research Workers in Animal Diseases. 2013; 14(1):68-77. Epub 2013/05/21.
13. Wang IN, Smith DL, Young R. Holins: the protein clocks of bacteriophage infections. Annu Rev Microbiol. 2000; 54:799-825. Epub 2000/10/06. doi: 10.1146/annurev.micro.54.1.799 PMID: 11018145
14. Fischetti VA. Bacteriophage lysins as effective antibacterials. Curr Opin Microbiol. 2008; 11(5):393-400. doi: 10.1016/j.mib.2008.09.012 PMID: 18824123
15. Nelson D, Loomis L, Fischetti VA. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci U S A. 2001; 98(7):4107-12. Epub 2001/03/22. doi: 10.1073/pnas.061038398 PMID: 11259652
16. Loeffler JM, Nelson D, Fischetti VA. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science. 2001; 294(5549):2170-2. doi: 10.1126/science.1066869 PMID: 11739958
17. Fischetti VA. Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol. 2005; 13(10):491-6. doi: 10.1016/j.tim.2005.08.007 PMID: 16125935
18. Daniel A, Euler C, Collin M, Chahales P, Gorelick KJ, Fischetti VA. Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2010; 54(4):1603-12. Epub 2010/01/21. doi: 10.1128/AAC.01625-09 PMID: 20086153
19. Cheng Q, Nelson D, Zhu S, Fischetti VA. Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob Agents Chemother. 2005; 49(1):111-7. Epub 2004/12/24. PubMed Central PMCID: PMC538902. doi: 10.1128/AAC.49.1.111-117.2005 PMID: 15616283
20. Harel J, Martinez G, Nassar A, Dezfulian H, Labrie SJ, Brousseau R, et al. Identification of an inducible bacteriophage in a virulent strain of Streptococcus suis serotype 2. Infection and immunity. 2003; 71(10):6104-8. Epub 2003/09/23. doi: 10.1128/IAI.71.10.6104-6108.2003 PMID: 14500539
21. Ma YL, Lu CP. Isolation and identification of a bacteriophage capable of infecting Streptococcus suis type 2 strains. Veterinary microbiology. 2008; 132(3-4):340-7. Epub 2008/08/05. doi: 10.1016/j.vetmic.2008.05.013 PMID: 18676101
22. Wang Y, Sun JH, Lu CP. Purified recombinant phage lysin LySMP: an extensive spectrum of lytic activity for swine streptococci. Current microbiology. 2009; 58(6):609-15. Epub 2009/03/10. doi: 10.1007/s00284-009-9379-x PMID: 19267155
23. Meng X, Shi Y, Ji W, Meng X, Zhang J, Wang H, et al. Application of a bacteriophage lysin to disrupt biofilms formed by the animal pathogen Streptococcus suis. Appl Environ Microbiol. 2011; 77(23):8272-9. Epub 2011/10/11. doi: 10.1128/AEM.05151-11 PMID: 21984241
24. Tang F, Li D, Wang H, Ma Z, Lu C, Dai J. Prophage lysin Ply30 protects mice from Streptococcus suis and Streptococcus equi subsp. zooepidemicus infections. Appl Environ Microbiol. 2015; 81(21):7377-84. doi: 10.1128/AEM.02300-15 PMID: 26253669
25. Gilmer DB, Schmitz JE, Euler CW, Fischetti VA. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2013; 57(6):2743-50. Epub 2013/04/11. doi: 10.1128/AAC.02526-12 PMID: 23571534
26. Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008; 3(2):163-75. Epub 2008/02/16. doi: 10.1038/nprot.2007.521 PMID: 18274517
27. Rouse MS, Rotger M, Piper KE, Steckelberg JM, Scholz M, Andrews J, et al. In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus. Antimicrob Agents Chemother. 2005; 49(8):3187-91. Epub 2005/07/29. doi: 10.1128/AAC.49.8.3187-3191.2005 PMID: 16048923
28. Pastagia M, Euler C, Chahales P, Fuentes-Duculan J, Krueger JG, Fischetti VA. A Novel Chimeric Lysin Shows Superiority to Mupirocin for Skin Decolonization of Methicillin-Resistant and -Sensitive Staphylococcus aureus Strains. Antimicrob Agents Chemother. 2011; 55(2):738-44. Epub 2010/11/26. doi: 10.1128/AAC.00890-10 PMID: 21098252
29. Seitz M, Beineke A, Seele J, Fulde M, Valentin-Weigand P, Baums CG. A novel intranasal mouse model for mucosal colonization by Streptococcus suis serotype 2. Journal of medical microbiology. 2012; 61(Pt 9):1311-8. Epub 2012/05/05. doi: 10.1099/jmm.0.043885-0 PMID: 22556325
30. Rashel M, Uchiyama J, Ujihara T, Uehara Y, Kuramoto S, Sugihara S, et al. Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. J Infect Dis. 2007; 196(8):1237-47. Epub 2007/10/24. doi: 10.1086/521305 PMID: 17955443
31. Schuch R, Nelson D, Fischetti VA. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature. 2002; 418(6900):884-9. Epub 2002/08/23. doi: 10.1038/nature01026 PMID: 12192412
32. Clifton-Hadley FA. Studies of Streptococcus suis type 2 infection in pigs. Veterinary research communications. 1984; 8(3):217-27. Epub 1984/08/01. PMID: 6495639
33. Robertson ID, Blackmore DK. Prevalence of Streptococcus suis types 1 and 2 in domestic pigs in Australia and New Zealand. The Veterinary record. 1989; 124(15):391-4. Epub 1989/04/15. PMID: 2658296
34. Robertson ID, Blackmore DK, Hampson DJ, Fu ZF. A longitudinal study of natural infection of piglets with Streptococcus suis types 1 and 2. Epidemiology and infection. 1991; 107(1):119-26. Epub 1991/08/01. PMID: 1879478
35. Amass SF, Wu CC, Clark LK. Evaluation of antibiotics for the elimination of the tonsillar carrier state of Streptococcus suis in pigs. Journal of veterinary diagnostic investigation: official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc. 1996; 8(1):64-7. Epub 1996/01/01.
36. Torremorell M, Calsamiglia M, Pijoan C. Colonization of suckling pigs by Streptococcus suis with particular reference to pathogenic serotype 2 strains. Canadian journal of veterinary research = Revue canadienne de recherche veterinaire. 1998; 62(1):21-6. Epub 1998/01/27. PMID: 9442935
37. Cloutier G, D'Allaire S, Martinez G, Surprenant C, Lacouture S, Gottschalk M. Epidemiology of Streptococcus suis serotype 5 infection in a pig herd with and without clinical disease. Veterinary microbiology. 2003; 97(1-2):135-51. Epub 2003/11/26. PMID: 14637045
38. Swildens B, Nielen M, Wisselink HJ, Verheijden JH, Stegeman JA. Elimination of strains of Streptococcus suis serotype 2 from the tonsils of carrier sows by combined medication and vaccination. The Veterinary record. 2007; 160(18):619-21. Epub 2007/05/08. PMID: 17483379
39. Djurkovic S, Loeffler JM, Fischetti VA. Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance. Antimicrob Agents Chemother. 2005; 49(3):1225-8. Epub 2005/02/25. doi: 10.1128/AAC.49.3.1225-1228.2005 PMID: 15728935
40. Schuch R, Lee HM, Schneider BC, Sauve KL, Law C, Khan BK, et al. Combination Therapy With Lysin CF-301 and Antibiotic Is Superior to Antibiotic Alone for Treating Methicillin-Resistant Staphylococcus aureus-Induced Murine Bacteremia. J Infect Dis. 2013.
41. Robinson JM, Hardman JK, Sloan GL. Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus. J Bacteriol. 1979; 137(3):1158-64. Epub 1979/03/01. PMID: 438117